
-
Stocks retreat as profit-taking follows Wall Street records
-
Israel expands campaign in Gaza ahead of Netanyahu's US visit
-
Barcelona's Ansu Fati aims to kick-start career in Monaco
-
Bordeaux-Begles drawn with Northampton in Champions Cup final repeat
-
Sean Combs trial: jurors seek verdict for a second day
-
Trump says will 'take a look' at deporting Musk
-
Greece starts charging tourist tax on cruises
-
Trump heads for 'Alligator Alcatraz' migrant detention center
-
US Senate push to pass Trump's unpopular spending bill enters second day
-
England captain Stokes relishing Pant battle in India series
-
Ukraine hits Russian city deep behind front line, leaves three dead
-
Hinault backs 'complete rider' Pogacar for Tour de France glory
-
Third seed Pegula suffers shock Wimbledon exit
-
Stocks struggle tracking US trade deal prospects
-
Djokovic launches Grand Slam history bid at Wimbledon
-
UK arrests three in Lucy Letby hospital probe
-
Europe on high alert as surprise early heatwave creeps north
-
UK govt faces major rebellion in welfare vote
-
Indian capital bans fuel for old cars in anti-pollution bid
-
Flintoff rules himself out of top England coaching job
-
Russia ramps up drone strikes on Ukraine in June: AFP analysis
-
Japan had hottest June on record: weather agency
-
Asian stocks rise on trade deal hopes, Tokyo hit by Trump warning
-
Thailand's PM suspended by Constitutional Court
-
Blur will return to musical oasis, says drummer Rowntree
-
CBEX crypto scam: AI-hyped Ponzi scheme defrauds African investors
-
Inzaghi hails 'extraordinary' Al Hilal after City upset
-
Man City, Inter Milan crash out of Club World Cup in last 16
-
North Korea's Kim shown honouring troops killed in Russia-Ukraine war
-
Saudi's Al Hilal knock Man City out of Club World Cup in huge shock
-
'In our blood': Egyptian women reclaim belly dance from stigma
-
Online memorial for children dead in Hiroshima, Nagasaki
-
US Senate in final push to pass Trump spending bill
-
Asian stocks rise on trade deal hopes, Tokyo hit by tariff warning
-
Hong Kong rights record under fire as it marks China handover anniversary
-
Bangladeshis cling to protest dreams a year after revolution
-
Djokovic, Sinner enter Wimbledon fray
-
European security tops Denmark's EU presidency priorities
-
France expecting peak temperatures as heatwave hits Europe
-
Germany eye return to women's football summit at Euro 2025
-
'Every day I see land disappear': Suriname's battle to keep sea at bay
-
England feel pressure to perform at Euros as stars pull out
-
Clashes in Istanbul over alleged 'Prophet Mohammed' cartoon
-
India face 'last-minute' Bumrah call as they bid to level England series
-
Dortmund up against 'superstar' Ramos, aggressive Monterrey: Kovac
-
US judge orders Argentina to sell 51% stake in oil firm YPF
-
SuperOrdinary Launches SuperOrdinary Studios to Power Creator-Led Entertainment
-
VelaFi Launches as the Next Evolution of TruBit Business, Powering Financial Infrastructure
-
Feed the Children Launches Summer Hunger Campaign and Expands Summer Feed & Read Program
-
CS Group Announces Strategic MOU Between CS Interpharm and Gulf Center Group for Customized Manufacturing Collaboration

US labels 'tranq' drug linked to fatal overdoses as 'emerging threat'
The US government on Wednesday designated xylazine, commonly known as "tranq," as an "emerging threat" and asked Congress for funding to fight the drug that has been increasingly linked to a surge in overdose deaths.
"This is the first time in our nation's history that a substance is being designated as an emerging threat by any administration," said Rahul Gupta, director of the White House Office of National Drug Control Policy.
Xylazine is an animal tranquilizer that is typically used by veterinarians to sedate large animals such as horses and deer.
It is not approved for use in humans but is commonly mixed with fentanyl, cocaine or heroin and is known by the street name "tranq," according to the US Drug Enforcement Administration (DEA).
Consumption of xylazine can lower one's blood pressure and heart rate to critically low levels and can cause skin ulcers and abscesses that can lead to amputation.
Gupta said the federal government will publish a plan within 90 days on ways to combat the overdose scourge caused by xylazine, also known as the "zombie drug."
The plan would look at increasing testing capacity, withdrawal management, treatment protocols and attacking the supply chain of illicit xylazine, he said.
"President Biden remains committed to beating the overdose crisis," Gupta said. "We need support from Congress for this and we'll continue to work with members of both parties on this urgent issue."
According to DEA figures, overdose deaths linked to xylazine increased by 1,127 percent in the south of the country from 2020 to 2021 -- from 116 to 1,423 -- and were substantially higher in other regions too.
A kilogram (2.2 pounds) of xylazine powder can be purchased online from Chinese suppliers for just $6-$20 dollars, according to the DEA.
O.M.Souza--AMWN